Today the San Diego Union Tribune featured a Q&A with Douglas Galasko, MD a principal investigator with the Parkinson's Progression Marker's Initiative (PPMI), MJFF’s landmark Parkinson’s biomarkers clinical study. Dr. Galasko heads the University of California San Diego School of Medicine study site.

Visit https://www.ppmi-info.org/ to find out more about PPMI and the search for a biomarker for PD.